匹莫苯丹

Pimobendan

未知生产厂商

生成 AI 研报

技术标识符

化学式: C₁₉H₁₈N₄O₂
CAS 编号: 74150-27-9
UNII ID: 34AP3BBP9T

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Pharmaceutical compositions of pimobendan
US 12257350 B2申请人: BOEHRINGER INGELHEIM VETMEDICA GMBH优先权: 2013
CN
EP
US
WO
15 件公开
Liquid preparation comprising pimobendan
US 9107952 B2申请人: FOLGER MARTIN优先权: 2006
CN
EP
US
9 件公开
Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
US 12011441 B2申请人: BOEHRINGER INGELHEIM VETMEDICA GMBH优先权: 2016
CN
EP
US
WO
8 件公开
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
US 10071162 B2申请人: AVEN MICHAEL优先权: 2013
CN
US
8 件公开
Pharmaceutical composition comprising pimobendan
- US 8846679 B2
  申请人: FOLGER MARTIN A优先权: 2004
  US
  7 件公开
- US 11246867 B2
  申请人: CEVA SANTE ANIMALE优先权: 2015
  US
SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS
EP 4633607 A1申请人: BOEHRINGER INGELHEIM VETMEDICA GMBH优先权: 2022
CN
EP
US
WO
4 件公开
COMPOSITION FOR PREVENTING HEART DISEASES CAUSED BY PULMONARY HYPERTENSION AND TREATING HEART, AND FUNCTIONAL FORMULATION COMPRISING SAME
EP 4643859 A4申请人: CARESIDE CO LTD优先权: 2023
CN
EP
US
WO
4 件公开
COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
US 2024390317 A1申请人: BOEHRINGER INGELHEIM VETMEDICA GMBH优先权: 2023
CN
EP
US
WO
4 件公开
GENE THERAPY METHODS FOR TREATING MITRAL VALVE DISEASE
EP 4590693 A2申请人: REJUVENATE BIO INC优先权: 2022
CN
EP
WO
3 件公开
Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
US 8680101 B2申请人: BOEREN MARINUS MARIA MARTINUS优先权: 2009
EP
US
3 件公开

药物

匹莫苯丹

专利

Pharmaceutical composition comprising pimobendan